This article provides a comprehensive guide for researchers and drug development professionals on reducing Process Mass Intensity (PMI) during the workup and isolation stages of pharmaceutical development.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on leveraging continuous manufacturing to significantly reduce Process Mass Intensity (PMI).
This article provides researchers, scientists, and drug development professionals with a comprehensive framework for reducing Process Mass Intensity (PMI) in biocatalytic processes.
This guide provides researchers, scientists, and drug development professionals with a comprehensive understanding of how to effectively use the ACS Green Chemistry Institute (GCI) Pharmaceutical Roundtable's Process Mass Intensity (PMI)...
This article provides a comprehensive overview of Process Analytical Technology (PAT) for real-time Process Monitoring and Improvement (PMI) in biopharmaceutical development and manufacturing.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on calculating and applying Process Mass Intensity (PMI) for drug substances.
This article provides a comprehensive guide to Process Mass Intensity (PMI) for researchers, scientists, and drug development professionals.
This article provides a comprehensive analysis of mass intensity metrics for researchers, scientists, and drug development professionals.
This article provides a systematic comparison of the greenness profiles of Normal-Phase (NP) and Reversed-Phase (RP) High-Performance Thin-Layer Chromatography (HPTLC) for pharmaceutical analysis.
This article provides a comprehensive comparison of two pivotal green analytical chemistry (GAC) tools—the Analytical Eco-Scale and the AGREE metric—tailored for researchers and professionals in drug development.